Cargando…
The c‐Src/LIST Positive Feedback Loop Sustains Tumor Progression and Chemoresistance
Chemotherapy resistance and treatment failure hinder clinical cancer treatment. Src, the first mammalian proto‐oncogene to be discovered, is a valuable anti‐cancer therapeutic target. Although several c‐Src inhibitors have reached the clinical stage, drug resistance remains a challenge during treatm...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369257/ https://www.ncbi.nlm.nih.gov/pubmed/37156751 http://dx.doi.org/10.1002/advs.202300115 |